Intrinsic Value of S&P & Nasdaq Contact Us

Compugen Ltd. CGEN NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
81/100
5/7 Pass
SharesGrow Intrinsic Value
$5.39
+86.5%
Analyst Price Target
$4.00
+38.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Compugen Ltd. (CGEN) trades at a trailing P/E of 6.3. Trailing earnings yield is 15.78%. Graham Number is $3.03.

Criteria proven by this page:

  • VALUE (96/100, Pass) — P/E is below market average (6.3); analyst target implies upside (+38.4%); earnings yield beats bond yields (15.78%).
  • Trailing Earnings Yield 15.78% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
  • Analyst consensus target $4.00 (+38.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 81/100 with 5/7 criteria passed.

SharesGrow 7-Criteria Score
81/100
SG Score
View full scorecard →
VALUE
96/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
GROWTH
100/100
→ Income
INCOME
100/100
→ Income

Valuation Snapshot — CGEN

Valuation Multiples
P/E (TTM)6.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.18
P/S Ratio3.09
EV/EBITDA4.1
Per Share Data
EPS (TTM)$0.37
Book Value / Share$1.09
Revenue / Share$0.77
FCF / Share$0.33
Yields & Fair Value
Earnings Yield15.78%
Dividend Yield0.00%
Graham Number$3.03
SharesGrow IV$5.39 (+86.5%)
Analyst Target$4.00 (+38.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -8.2 -0.15 4.08 364.28 -
2017 -3.7 -0.23 4.72 0.00 -
2018 -5.3 0.12 3.22 6.74 -
2019 -13.9 -2.84 9.90 0.00 -
2020 -32.5 2.33 8.05 481.92 -
2021 -10.6 -0.98 3.39 60.35 -
2022 -1.8 0.38 0.80 8.26 -
2023 -9.3 0.20 2.67 5.24 -
2024 -9.6 0.40 2.49 4.92 -
2025 4.0 -0.01 1.39 1.96 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.62 $712K $-31.51M -4425%
2017 $-0.72 $0.00 $-37.07M -
2018 $-0.41 $17.8M $-22.6M -127%
2019 $-0.43 $0.00 $-27.34M -
2020 $-0.34 $2M $-27.26M -1363%
2021 $-0.39 $6M $-32.87M -547.9%
2022 $-0.39 $7.5M $-33.69M -449.3%
2023 $-0.21 $33.46M $-18.75M -56.1%
2024 $-0.16 $27.86M $-14.23M -51.1%
2025 $0.38 $72.76M $35.34M 48.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.22 $-0.28 – $-0.11 $14.56M $9.4M – $19.71M 4
2027 $-0.12 $-0.22 – $0.08 $41.23M $25.46M – $56.99M 3
2028 $-0.21 $-0.31 – $-0.11 $40.62M $25.4M – $55.83M 5
2029 $-0.28 $-0.42 – $-0.14 $47.89M $29.94M – $65.82M 1
2030 $-0.16 $-0.24 – $-0.08 $57.84M $36.16M – $79.49M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message